Incannex Healthcare Limited Common Stock
IXHL
2 hedge funds and large institutions have $8K invested in Incannex Healthcare Limited Common Stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 4 closing their positions.
0.17% less ownership
Funds ownership: 0.17% → 0% (-0.17%)
67% less funds holding
Funds holding: 6 → 2 (-4)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $736K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$378K |
| 2 |
Morgan Stanley
New York
|
-$128K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$110K |
| 4 |
Old Mission Capital
Chicago,
Illinois
|
-$92K |
| 5 |
Barclays
London,
United Kingdom
|
-$16K |
IXHL Hedge Fund Activity: Q2 2022 in Review
2 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in Incannex Healthcare Limited Common Stock (IXHL) for Q2 2022, worth a combined $8K — down 99% from $804K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IXHL and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $378K sold.
- 2 institutional investors held Incannex Healthcare Limited Common Stock (IXHL) as of Q2 2022, down from 6 in Q1 2022.
- Funds reported $8K of Incannex Healthcare Limited Common Stock stock for Q2 2022, down 99% quarter-over-quarter.
- 0 funds opened new Incannex Healthcare Limited Common Stock positions in Q2 2022 and 4 closed out, a net change of -4 holders.
- The largest Incannex Healthcare Limited Common Stock seller in Q2 2022 was Jane Street, an estimated $378K sold.
Based on aggregated 13F filings for Q2 2022.